Pertussis in Latin America: Recent epidemiological data presented at the 2017 Global Pertussis Initiative meeting |
| |
| Institution: | 1. Instituto de Biotecnología y Biología Molecular, Facultad de Ciencias Exactas, Universidad Nacional de La Plata-CONICET, La Plata, Argentina;2. PediaClinic, Centro de Especialidades Pediátricas, San José, Costa Rica;3. Medico Infectólogo, Hospital Militar Central, Bogotá, Colombia;4. Labor:Medizin Krefeld MVZ, Krefeld, Germany;5. Feinberg School of Medicine, Northwestern University, Chicago, IL, USA;6. Flinders University and Flinders Medical Centre, Bedford Park, Adelaide, Australia;1. Department of Paediatrics, Chinese University of Hong Kong, Hong Kong, China;2. Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland;1. Expanded Program on Immunization Department, Tianjin Center for Disease Control and Prevention, Tianjin, People’s Republic of China;2. Institute of Medical Support Technology, Academy of Military Sciences, Tianjin, People’s Republic of China;3. Expanded Program on Immunization Department, Binhai Center for Disease Control and Prevention, Tianjin, People’s Republic of China;4. Division of Epidemiology and Biostatistics, School of Public Health, The University of Hong Kong, Hong Kong Special Administrative Region;1. Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK;2. Laboratory of Respiratory and Special Pathogens, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD, USA;1. “R. Gutiérrez” Children’s Hospital, Epidemiology, 1330 Gallo St, PO 1425, Buenos Aires, Argentina;2. “R. Gutiérrez” Children’s Hospital, Virology, 1330 Gallo St, PO 1425, Buenos Aires, Argentina;1. Microbiology and Immunology Program, Institute of Biomedical Sciences, College of Medicine, University of Chile, Santiago, Chile;2. Millennium Institute of Immunology and Immunotherapy, College of Medicine, University of Chile, Santiago, Chile;3. University of South Florida, College of Public Health, Panama Program, City of Knowledge, Panama;4. Department of Health Sciences, College of Health Professions and Sciences, Academic Health Sciences Center, University of Central Florida, Orlando, FL, United States;5. Department of Population Health Sciences, College of Medicine, Academic Health Sciences Center, University of Central Florida, Orlando, FL, United States;6. Sanofi Pasteur, Lyon, France;1. Public Health Agency of Sweden, Solna, Sweden;2. University of Bordeaux, National Institute for Health and Medical Research (Inserm), Bordeaux Population Health Research Center, Bordeaux, France;3. University Hospital Centre CHU, Bordeaux, France;4. EUCLID/F-CRIN Clinical Trials Platform, Bordeaux, France;5. Inria SISTM team, F-33405, Talence, France;6. Karolinska Trial Alliance, Karolinska University Hospital, Stockholm, Sweden;7. ILiAD Biotechnologies, New York, NY, USA;8. University of Lille, National Centre for Scientific Research (CNRS), National Institute for Health and Medical Research (Inserm), University Hospital Centre CHU Lille, Lille, France;9. Center for Infection and Immunity of Lille, Institut Pasteur de Lille, Lille, France |
| |
| Abstract: | The Global Pertussis Initiative (GPI) is an expert scientific forum that publishes consensus recommendations for pertussis monitoring, prevention, and treatment across many regions of the world. Here, we report on the regional 2017 GPI meeting on the Americas, focusing on Latin America. Information on current pertussis epidemiology, surveillance, vaccine strategies, diagnostic capabilities, disease awareness, and major local obstacles was presented by researchers from Argentina, Brazil, Colombia, Costa Rica, El Salvador, Mexico, Peru, Puerto Rico, Uruguay, and Venezuela. Pertussis outbreaks have occurred during the last decade in the majority of participant countries and have been followed by improvements in surveillance. In the countries that introduced maternal immunization during pregnancy, a reduction in the infant case fatality rate has been detected. All countries need to maintain and improve pertussis surveillance to reach primary vaccination coverage >90%. Moreover, countries without maternal immunization programs should strongly consider them. |
| |
| Keywords: | Epidemiology Latin America Pertussis Vaccination |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
